Predicting the effectiveness of methotrexate therapy based on basal expression of the AMP-activated protein kinase gene in the blood of patients with rheumatoid arthritis
Objective: to search for an association between basal expression of the AMP-activated protein kinase (adenosine monophosphate-activated protein kinase, AMPK) gene in the blood of patients with rheumatoid arthritis (RA) and disease activity, as well as joint destruction before and after 24 months of...
Main Authors: | E. V. Chetina, N. V. Demidova, G. A. Markova, E. P. Salyanova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2022-02-01
|
Series: | Современная ревматология |
Subjects: | |
Online Access: | https://mrj.ima-press.net/mrj/article/view/1251 |
Similar Items
-
Metabolic aspects of clinical remission prediction from baseline blood gene expression in patients with rheumatoid arthritis treated with methotrexate
by: E. V. Chetina, et al.
Published: (2019-05-01) -
Association between a low baseline level of gene expression of energy metabolism in the blood and the development of clinical remission in response to tofacitinib therapy in patients with rheumatoid arthritis
by: E. V. Chetina, et al.
Published: (2021-06-01) -
The gene expression of caspase 3, matrix metalloproteinase-9, tissue inhibitor of metalloproteinases-1, and cathepsins S and K in patients with osteoarthritis requiring large joint replacement
by: E. V. Chetina, et al.
Published: (2020-05-01) -
The role of clinical parameters and cathepsin S gene expression in predicting the development of postoperative pain in patients with hip osteoarthritis
by: E. V. Chetina, et al.
Published: (2023-02-01) -
Prediction of the development of postoperative pain in patients with late-stage knee osteoarthritis based on the expression of genes for degradation of the extracellular matrix, inflammation and apoptosis in the blood
by: E. V. Chetina, et al.
Published: (2022-06-01)